To evaluate whether the prolonged consumption of flaxseed minimize the factors that trigger MS in healthy rats.
Introduction
Metabolic syndrome (MS) is the most common disease today, representing one of the major public health problems of the century, and its incidence has gradually increased over time 1, 2 . Its prevalence varies worldwide, because it is directly related to aging, ethnicity of the studied populations, and criteria for its diagnosis.
It is estimated that one quarter of the world population has MS 3, 4 .
This metabolic alteration consists of a simultaneous presence of a set of cardiovascular risk factors 5 characterized by hypertension, abdominal obesity, increased triglycerides, decreased high density lipoproteins (HDL-c), and increased glycemia/type 2 diabetes 6-1 .
Preventive measures and therapeutic strategies, such as changes in lifestyle including nutrition interventions and physical activity, are the possible ways to avoid the onset of MS 6 .
Flax plant is the most abundant source of omega-3
(α-linolenic acid, ALA) and can be easily found, as well as being cheaper than the fish oil, which is also the source of this fatty acid 7 . ALA is an essential polyunsaturated fatty acid dependent on foods ingestion that contain it, since it cannot be synthesized by the human body.
From 41% of the total fat present in flaxseed oil, 57% come from the omega 3, which has anti-inflammatory, antithrombotic, and antiarrhythmic properties 8 .
Based on the results of clinical trials, epidemiological investigations, and experimental studies, it has been suggested that ALA intake has a high impact on cardiovascular disease (CVD), which, in turn, led to an increased consumption of polyunsaturated fatty acid. For this reason, the use of flaxseed has been advocated in the prevention of heart disease and therefore the MS, which is currently the most common metabolic disease among these patients 9 .
Flaxseed also contains other components with beneficial effects on the organism, such as dietary fiber and lignans, from which the Secoisolariciresinol diglucoside (SDG) is the main 10 .
This oilseed is considered a functional food, producing metabolic and physiological health benefits, in addition to its nutritional properties. Its consumption has been increasing progressively because it is a popular alternative to pharmacological treatment 11 .
Many studies have shown its positive effects when used as a supplemental feeding. These effects are manifested as improvement in lipid profile 12 , reducing the development of type 1 and type 2 diabetes mellitus 13 , reducing blood pressure 14 , and controlling weight gain 15 .
Taking into account the mentioned researches, the hypothesis of this work is that prolonged consumption of flaxseed During the experiment, the animals were kept in polypropylene cages at 22°C room temperature and controlled periods of light/dark (12/12 hours), receiving water and food ad libitum. The weight and feed consumption were monitored three times per week until the end of the experiment.
Experimental diets
The flaxseeds were weighed and crushed in a blender to obtain the flour that was weighed, packed, stored in refrigerator, A diet based on flaxseed did not receive oil nor cellulose in its prepare, because this seed is extremely rich in fiber and lipids (Table 1) . Animals' weight is used to assess the variation of animals' body mass, which were weighed three times a week on Gehara 
Statistical analysis
Data were presented as mean and standard deviation.
Statistical analysis was performed with S-Plus software for Windows 6.0 and p values less than 0.05 were considered significant. Kolmogorov-Smirnov test was used to determine if the data had normal distribution. Student's t test was applied for data with normal distribution and Wilcoxon rank-sum test for the others (Mann Whitney).
Results
It was found that both groups had similar values for PER (p=0.2667), CEA (p=0.0829), and GI (p=0.958). Dietary intake (p=0.032) and protein intake (p=0.032) during the 200 days of the experiment were significantly lower in the group treated with flaxseed (FG) than in the control group. There was no difference among initial weights of offspring in the experimental groups (p=0.422). However, at the assay end, animals supplemented with flaxseed had lower weight gain than the ones from CG (p=0.001) ( Table 2) . Analyzing the biochemical parameters, the values of total cholesterol (p<0.001) and triglycerides (p=0.0001) in FG are lower than in CG. The group supplemented with flaxseed showed higher numerical value in HDL-C levels, but no significant differences in relation to non-supplemented group. There was a better glycemic profile in FG (p=0.001). The visceral fat mass (VFM) was not significantly different between groups; a reduction of 16% was noted, however, in the group treated with flaxseed (FG) ( Table 3) . The total food and protein consumption were measured during the experiment in order to evaluate the food profile of the studied groups. There was a significant difference in consumption, lower in the FG than in CG. This can be justified by the seed composition, which is rich in soluble fiber. These fibers are viscous, hydrate easily, and have a great ability to form gel 20 . This leads to a decrease in the velocity of gastric emptying, and prolongation of satiety, resulting in reduced food intake 21 .
As for the effects caused by the oilseeds consumption on the weight gain of evaluated animals, these results corroborate those ones reported by other authors in studies with rodents 22 .
In this study, the weight of offspring at birth was similar in both groups, however, at the end of 200 days of experiment, the animals that fed a rich diet in flaxseed weighed significantly lower than the other ones, showing that flaxseed can prevent excess weight gain even in healthy rats. These results are satisfactory, since they show that weight loss did not affect the animals' GI from FC, which was similar to the CG. Daleprane et al. 23 supplemented weaned rats with 25% of flaxseed up to 180 days old and found lower body weight in animals that consumed the oilseed, although the growth rate has been similar to the CG. Weight loss is recommended as a strategy to reduce the risk of cardiovascular disease 24 .
Wu et al. 25 for coronary arterial disease 38 .
The flaxseed was associated with lower blood glucose in the supplemented group with flaxseed diet (FG). This result may indicate that the seed improves insulin sensitivity, thereby increasing glucose uptake. In a recent study, it was found that the flaxseed has hypoglycemic effect on diabetic rats 39 , and SDG present in flaxseed provides better glycemic control in hypercholesterolemic humans 37 . One possible cause for this glycemia reduction is the presence of SDG, which reduces diabetes incidence through its antioxidant activity. Oxidative stress has been suggested as a possible cause for type 1 and type 2 diabetes 40 .
One limitation of this study refers to the natural inability for direct extrapolation of the results from animal models to human beings. However, animal models are widely used to investigate the metabolic mechanisms.
Conclusions
The risk factors for metabolic syndrome development and, therefore, for cardiovascular disease may be minimized by prolonged flaxseed consumption, since there was improvement in lipid and glycemic profile, and present anti-obesogenic action.
Soon, flaxseed can be an affordable alternative in the adjuvant treatment of obesity and dyslipidemia.
